Tumor classification of gastrointestinal liver metastases using CT-based radiomics and deep learning.


Journal

Cancer imaging : the official publication of the International Cancer Imaging Society
ISSN: 1470-7330
Titre abrégé: Cancer Imaging
Pays: England
ID NLM: 101172931

Informations de publication

Date de publication:
05 Oct 2023
Historique:
received: 14 06 2022
accepted: 17 09 2023
medline: 26 10 2023
pubmed: 6 10 2023
entrez: 5 10 2023
Statut: epublish

Résumé

The goal of this study is to demonstrate the performance of radiomics and CNN-based classifiers in determining the primary origin of gastrointestinal liver metastases for visually indistinguishable lesions. In this retrospective, IRB-approved study, 31 pancreatic cancer patients with 861 lesions (median age [IQR]: 65.39 [56.87, 75.08], 48.4% male) and 47 colorectal cancer patients with 435 lesions (median age [IQR]: 65.79 [56.99, 74.62], 63.8% male) were enrolled. A pretrained nnU-Net performed automated segmentation of 1296 liver lesions. Radiomics features for each lesion were extracted using pyradiomics. The performance of several radiomics-based machine-learning classifiers was investigated for the lesions and compared to an image-based deep-learning approach using a DenseNet-121. The performance was evaluated by AUC/ROC analysis. The radiomics-based K-nearest neighbor classifier showed the best performance on an independent test set with AUC values of 0.87 and an accuracy of 0.67. In comparison, the image-based DenseNet-121-classifier reached an AUC of 0.80 and an accuracy of 0.83. CT-based radiomics and deep learning can distinguish the etiology of liver metastases from gastrointestinal primary tumors. Compared to deep learning, radiomics based models showed a varying generalizability in distinguishing liver metastases from colorectal cancer and pancreatic adenocarcinoma.

Identifiants

pubmed: 37798797
doi: 10.1186/s40644-023-00612-4
pii: 10.1186/s40644-023-00612-4
pmc: PMC10557291
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

95

Informations de copyright

© 2023. International Cancer Imaging Society (ICIS).

Références

Cancers (Basel). 2021 Nov 16;13(22):
pubmed: 34830885
Cancer Imaging. 2019 Feb 27;19(1):11
pubmed: 30813956
Radiology. 2016 Feb;278(2):563-77
pubmed: 26579733
Magn Reson Imaging. 2012 Nov;30(9):1323-41
pubmed: 22770690
Diagnostics (Basel). 2022 Dec 26;13(1):
pubmed: 36611358
Nat Commun. 2020 Feb 5;11(1):728
pubmed: 32024849
Eur Radiol. 2018 Dec;28(12):5284-5292
pubmed: 29882070
Radiology. 2018 Aug;288(2):318-328
pubmed: 29944078
Eur Radiol. 2021 Feb;31(2):834-846
pubmed: 32851450
Cancers (Basel). 2022 Mar 24;14(7):
pubmed: 35406418
Cancer Res. 2017 Nov 1;77(21):e104-e107
pubmed: 29092951
Front Oncol. 2022 Jan 07;11:689509
pubmed: 35070948
Nat Rev Cancer. 2019 Dec;19(12):686-697
pubmed: 31519982
Cancer Cell. 2018 Jul 9;34(1):148-162.e7
pubmed: 29990497
Front Oncol. 2021 Jan 29;10:581210
pubmed: 33585197
Sci Rep. 2021 May 11;11(1):9984
pubmed: 33976268
Nat Med. 2021 Feb;27(2):212-224
pubmed: 33574607
Neuroimage Clin. 2016 Nov 20;13:264-270
pubmed: 28018853
Radiol Imaging Cancer. 2021 Apr;3(4):e200157
pubmed: 34114913
PLoS One. 2014 May 07;9(5):e96873
pubmed: 24804720
Nat Rev Cancer. 2018 Aug;18(8):500-510
pubmed: 29777175
Cancers (Basel). 2022 Jan 29;14(3):
pubmed: 35158980
Cancers (Basel). 2021 Jun 20;13(12):
pubmed: 34203103
Curr Oncol Rep. 2019 Jun 25;21(8):70
pubmed: 31240403
Nat Rev Dis Primers. 2021 Apr 15;7(1):27
pubmed: 33859205
Nat Methods. 2021 Feb;18(2):203-211
pubmed: 33288961
Cancer Epidemiol. 2020 Aug;67:101760
pubmed: 32562887

Auteurs

Hishan Tharmaseelan (H)

Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.

Abhinay K Vellala (AK)

Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.

Alexander Hertel (A)

Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.

Fabian Tollens (F)

Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.

Lukas T Rotkopf (LT)

Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
German Cancer Research Center, E010 Radiology, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.

Johann Rink (J)

Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.

Piotr Woźnicki (P)

Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.

Isabelle Ayx (I)

Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.

Sönke Bartling (S)

Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.

Dominik Nörenberg (D)

Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.

Stefan O Schoenberg (SO)

Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.

Matthias F Froelich (MF)

Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. matthias.froelich@medma.uni-heidelberg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH